Discussion on: Angiotensin System Blockers in Experimental NAFLD/MASLD: Is there a Preferential Pathway or Drug?

Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.

Article Title
Angiotensin System Blockers in Experimental NAFLD/MASLD: Is there a Preferential Pathway or Drug?
Authored by

Mario Claudio Soares Sturzeneker
Department of Medicine, State University of Ponta Grossa, Ponta Grossa, Paraná, Brazil.

Flávia Cristina Colmenero
Department of Medicine, State University of Ponta Grossa, Ponta Grossa, Paraná, Brazil.

Jaqueline Meert Parlow
Department of Medicine, State University of Ponta Grossa, Ponta Grossa, Paraná, Brazil.

Isabela Hess Justus
Department of Medicine, State University of Ponta Grossa, Ponta Grossa, Paraná, Brazil.

Crisangela Cristin Consul
Department of Medicine, State University of Ponta Grossa, Ponta Grossa, Paraná, Brazil.

Gabriel dos Santos
Department of Medicine, State University of Ponta Grossa, Ponta Grossa, Paraná, Brazil.

Maíza Pellissari Migliorini
Department of Medicine, State University of Ponta Grossa, Ponta Grossa, Paraná, Brazil.

Karyn Maria Wenglarek
Department of Medicine, State University of Ponta Grossa, Ponta Grossa, Paraná, Brazil.

Thais de Lima da Silva
Department of Medicine, State University of Ponta Grossa, Ponta Grossa, Paraná, Brazil.

DOI or Article Link

https://doi.org/10.9734/jammr/2024/v36i115635

Leave a Comment